Metal-Based Anticancer Complexes and p53: How Much Do We Know?
Cancers · 19.05.2023 · 15 (10) · 2834
DOI: 10.3390/cancers15102834 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 19.05.2023. Verfasst von Samah Mutasim Alfadul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR 999077, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: City University of Hong Kong, Government of Hong Kong, Pneumoconiosis Compensation Fund Board.
Abstract (Originalsprache)
P53 plays a key role in protecting the human genome from DNA-related mutations; however, it is one of the most frequently mutated genes in cancer. The P53 family members p63 and p73 were also shown to play important roles in cancer development and progression. Currently, there are various organic molecules from different structural classes of compounds that could reactivate the function of wild-type p53, degrade or inhibit mutant p53, etc. It was shown that: (1) the function of the wild-type p53 protein was dependent on the presence of Zn atoms, and (2) Zn supplementation restored the altered conformation of the mutant p53 protein. This prompted us to question whether the dependence of p53 on Zn and other metals might be used as a cancer vulnerability. This review article focuses on the role of different metals in the structure and function of p53, as well as discusses the effects of metal complexes based on Zn, Cu, Fe, Ru, Au, Ag, Pd, Pt, Ir, V, Mo, Bi and Sn on the p53 protein and p53-associated signaling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Drug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR 999077, China.
ORCID-Profile: Samah Mutasim Alfadul, Maria V Babak
Förderung
- City University of Hong Kong
- Government of Hong Kong
- Pneumoconiosis Compensation Fund Board
Zitieren
APA
Alfadul, S. M., Matnurov, E. M., Varakutin, A. E., & Babak, M. V. (2023). Metal-Based Anticancer Complexes and p53: How Much Do We Know?. Cancers, 15(10), 2834. https://doi.org/10.3390/cancers15102834
Vancouver
Alfadul SM, Matnurov EM, Varakutin AE, Babak MV. Metal-Based Anticancer Complexes and p53: How Much Do We Know?. Cancers. 2023;15(10):2834. doi:10.3390/cancers15102834
BibTeX
@article{Alfadul2023,
author = {Alfadul, Samah Mutasim and Matnurov, Egor M and Varakutin, Alexander E and Babak, Maria V},
title = {Metal-Based Anticancer Complexes and p53: How Much Do We Know?},
journal = {Cancers},
year = {2023},
volume = {15},
number = {10},
pages = {2834},
doi = {10.3390/cancers15102834}
}
EUVIMED